FAST NEWS: Everest Medicines gets new drug license from Kezar Life
The latest: Everest Medicines Ltd. (1952.HK) announced Thursday that it has received an exclusive license from Kezar Life Sciences (KZR.US) to develop, manufacture and commercialize Zetomipzomib, a treatment for autoimmune diseases,…
1952.HK
FAST NEWS: Beigene stock falls after Novartis terminates partnership
The latest: Cancer drug maker BeiGene Ltd. (BGNE.US; 6160.HK; 668235.SH) announced Tuesday that Novartis (NOVN.SWX) will relinquish its rights to co-develop, produce and commercialize BeiGene’s esophagus cancer drug tislelizumab. Looking up: Novartis will provide…
BGNE.US
6160.HK
FAST NEWS: United Lab sinks after top shareholder sells down stake at discount
The latest: The United Laboratories International Holdings Ltd. (3933.HK) announced Tuesday its controlling shareholder, Heren Far East Ltd., on Monday was selling up to 64 million shares, or about 3.52%…
3933.HK
FAST NEWS: FWD Group delays Hong Kong IPO plan again
The latest: The latest IPO prospectus from FWD Group Holdings Ltd. lapsed early this month, further delaying the regional insurer’s listing after its fourth application. The company decided to postpone its…
FAST NEWS: ZhongAn’s gross written premium growth slows
The latest: Online insurer ZhongAn Online P & C Insurance Co. Ltd. (6060.HK) announced Wednesday its aggregate gross written premiums in the first eight months of this year totaled about 20.7 billion yuan…
6060.HK
FAST NEWS: JW Therapeutics to expand collaboration with 2Seventy Bio
The latest: Drug maker JW (Cayman) Therapeutics Co. Ltd. (2126.HK) said on Tuesday it is in talks to expand its strategic alliance with 2Seventy Bio (TSVT.US), which began with a partnership established in…
2126.HK